Cochrane Abstracts
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer Edited (no change to conclusions)
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Poly(ADP‐ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435279/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer_Edited__no_change_to_conclusions_. Accessed 23 October 2020.
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435279/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer_Edited__no_change_to_conclusions_. Accessed October 23, 2020.
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer Edited (no change to conclusions). In Cochrane Abstracts Retrieved October 23, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/435279/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer_Edited__no_change_to_conclusions_
Poly(ADP‐ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2020 October 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435279/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer Edited (no change to conclusions)
ID - 435279
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435279/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
